Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS.
Phillipe MoreauAjai ChariAlbert OrtiolJoaquin Martinez-LopezMathias HaenelCyrille TouzeauSikander AilawadhiBritta BesemerJavier de la RubiaCristina EncinasMaria-Victoria Mateos-MantecaHans J SalwenderPaula Rodriguez-OteroCyrille HulinLionel KarlinAnna Sureda BalariJoan BargayLotfi BenboubkerLaura RosinolStefano TarantoloHoward TerebeloShiyi YangJianping WangIvo NnaneMing QiMichele KoshMaria DelioukinaHartmut GoldschmidtPublished in: Blood cancer journal (2023)